Does AMLODIPINE Cause Cardiovascular insufficiency? 41 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 41 reports of Cardiovascular insufficiency have been filed in association with AMLODIPINE (Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide). This represents 0.1% of all adverse event reports for AMLODIPINE.
41
Reports of Cardiovascular insufficiency with AMLODIPINE
0.1%
of all AMLODIPINE reports
8
Deaths
24
Hospitalizations
How Dangerous Is Cardiovascular insufficiency From AMLODIPINE?
Of the 41 reports, 8 (19.5%) resulted in death, 24 (58.5%) required hospitalization, and 23 (56.1%) were considered life-threatening.
Is Cardiovascular insufficiency Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMLODIPINE. However, 41 reports have been filed with the FAERS database.
What Other Side Effects Does AMLODIPINE Cause?
Hypotension (6,504)
Toxicity to various agents (5,554)
Completed suicide (5,267)
Drug ineffective (4,091)
Dyspnoea (3,907)
Dizziness (3,536)
Intentional overdose (3,427)
Fall (3,215)
Fatigue (3,141)
Headache (2,907)
What Other Drugs Cause Cardiovascular insufficiency?
FUROSEMIDE (51)
METFORMIN (47)
SACUBITRIL\VALSARTAN (38)
SODIUM (36)
DEXAMETHASONE (34)
BISOPROLOL (32)
FLUCONAZOLE (31)
METHYLPREDNISOLONE (30)
DEXTROSE (29)
CARBIDOPA\LEVODOPA (28)
Which AMLODIPINE Alternatives Have Lower Cardiovascular insufficiency Risk?
AMLODIPINE vs AMLODIPINE BESILATE
AMLODIPINE vs AMLODIPINE\ATORVASTATIN
AMLODIPINE vs AMLODIPINE\BENAZEPRIL
AMLODIPINE vs AMLODIPINE\HYDROCHLOROTHIAZIDE\OLMESARTAN
AMLODIPINE vs AMLODIPINE\HYDROCHLOROTHIAZIDE\OLMESARTAN MEDOXOMIL